TrialAIDS research and human retroviruses2009

Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.

Allan R Tenorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.